Monoclonal Antibodies Partnering Terms and Agreements
Reportstack, provider of premium market research reports announces the addition of Monoclonal Antibodies Partnering Terms and Agreements market report to its offering
The report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
View full press release